Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.66 USD | -1.93% | -1.57% | -16.39% |
Feb. 09 | HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating | MT |
Feb. 08 | Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 49
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Discovery and Development of Innovative Drug
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 16-03-28 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 22-07-25 |
Chief Tech/Sci/R&D Officer | - | 22-01-02 | |
Chief Tech/Sci/R&D Officer | - | 19-08-12 | |
Chief Tech/Sci/R&D Officer | 61 | 11-08-31 | |
Mark W. Noel
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-02-28 |
Rachel Blasbalg
HRO | Human Resources Officer | - | 03-12-31 |
Dora Ferrari
PRN | Corporate Officer/Principal | - | 21-01-02 |
Nancy Soohoo
LAW | General Counsel | - | 02-12-31 |
Jonathan Zung
PRN | Corporate Officer/Principal | 59 | 23-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 03-10-31 | |
Chairman | 82 | 00-02-13 | |
James Dentzer
CEO | Chief Executive Officer | 57 | 16-03-28 |
Marc Rubin
BRD | Director/Board Member | 69 | 10-06-02 |
Chief Tech/Sci/R&D Officer | 61 | 11-08-31 | |
Anne Borgman
BRD | Director/Board Member | 56 | - |
John Hohneker
BRD | Director/Board Member | 64 | 21-12-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,894,085 | 5,879,121 ( 99.75 %) | 0 | 99.75 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.75% | 64.07M | |
+9.16% | 45.97B | |
+53.58% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Curis, Inc. - Nasdaq
- Company Curis, Inc.